KNSA vs WELL · P/E 53, rev $677.6M vs P/E 100, rev $10.84B
Kiniksa Pharmaceuticals Ltd (KNSA) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
KNSA currently screens at market cap $3.73B and trailing P/E 53.2. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the KNSA and WELL stock pages for the full models.
Not investment advice.